TCTR20210326006进行中（未招募）2 期
A double-blind randomized placebo-controlled study of Desvenlafaxine for managing vasomotor symptoms in breast cancer survivors
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 Years 至 60 Years（—）
- 性别
- Female
入选标准
- •Women, who were diagnosed breast cancer, have moderate to severe vasomotor symptoms
排除标准
- •1. Allergy to SSRI and SNRI
- •2. Hormonal treatment within 4 weeks prior
- •3. History of epilepsy
- •4. History of myocardial infarction within 6 months prior
- •5. History of depression, bipolar disease or psychological conditions
- •6. History of glaucoma or increased intraocular pressure
- •7. Malabsorption
- •8. Hypertension
- •9. Impaired liver or renal disease
研究者
相似试验
已完成
2 期
Efficacy of Ashwagandha extract on generalized anxiety disorderCTRI/2022/04/042133Arjuna Natural Private Limited60
已完成
不适用
A randomized double-blind placebo-controlled study for effects of aged garlic extract on fatigueJPRN-UMIN000017095Momoya Co., Ltd.40
进行中（未招募）
1 期
ALASCCA-A randomized double-blind placebo-controlled study with ASAtreatment in colorectal cancer patients with mutations in the PI3Ksignaling pathway.Colon or rectal cancer tumor stage II-III, tumor with somatic alterationsin PIK3CA, PIK3R1 or PTEN.MedDRA version: 21.0Level: LLTClassification code 10010029Term: Colorectal cancer NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-004240-19-DKKarolinska University Hospital, Department of Molecular medicine and Surgery Karolinska Institutet, Gastrocentrum600
招募中
3 期
ALASCCA-A randomized double-blind placebo-controlled study with ASA treatment in colorectal cancer patients with mutations in the PI3K signaling pathway2024-513778-23-00Karolinska Institutet700
已完成
3 期
To determine whether Flexsure is safe, tolerable and effective in relieving symptoms of moderate osteoarthritis of the knee.CTRI/2011/07/001911Vital gNetics60